ELOVL4

Last updated
ELOVL4
Identifiers
Aliases ELOVL4 , ADMD, CT118, ISQMR, SCA34, STGD2, STGD3, ELOVL fatty acid elongase 4
External IDs OMIM: 605512 MGI: 1933331 HomoloGene: 41488 GeneCards: ELOVL4
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_022726

NM_148941

RefSeq (protein)

NP_073563

NP_683743

Location (UCSC) Chr 6: 79.91 – 79.95 Mb Chr 9: 83.66 – 83.69 Mb
PubMed search [3] [4]
Wikidata
View/Edit Human View/Edit Mouse

Elongation of very long chain fatty acids protein 4 is a protein that in humans is encoded by the ELOVL4 gene. [5] [6]

Contents

ELOVL4 is a member of a large family of fatty acid elongases (ELO) that catalyzes the rate-limiting step in the elongation of long chain fatty acids (LC-FA) into very long-chain saturated (VLC-SFA) and polyunsaturated (VLC-PUFA) fatty acids, collectively known as VLC-FA (very long chain fatty acid). [7] [8] ELOVL4 and its products are found in the brain, skin, retina, meibomian glands, testes and sperm. [9] [10] [11] [12] [13] [14] [15] Known mutations of ELOVL4 in humans cause diseases such as Autosomal Dominant Stargardt-like Macular Dystrophy (STGD3), spinocerebellar ataxia-34 (SCA34), skin deformities and seizures. [16] [17] [18] [19] [20] [21] [22] [23] [24] [25]

See also

Related Research Articles

In genetics, anticipation is a phenomenon whereby as a genetic disorder is passed on to the next generation, the symptoms of the genetic disorder become apparent at an earlier age with each generation. In most cases, an increase in the severity of symptoms is also noted. Anticipation is common in trinucleotide repeat disorders, such as Huntington's disease and myotonic dystrophy, where a dynamic mutation in DNA occurs. All of these diseases have neurological symptoms. Prior to the understanding of the genetic mechanism for anticipation, it was debated whether anticipation was a true biological phenomenon or whether the earlier age of diagnosis was related to heightened awareness of disease symptoms within a family.

<span class="mw-page-title-main">Vitelliform macular dystrophy</span> Medical condition

Vitelliform macular dystrophy is an irregular autosomal dominant eye disorder which can cause progressive vision loss. This disorder affects the retina, specifically cells in a small area near the center of the retina called the macula. The macula is responsible for sharp central vision, which is needed for detailed tasks such as reading, driving, and recognizing faces. The condition is characterized by yellow, slightly elevated, round structures similar to the yolk of an egg.

Stargardt disease is the most common inherited single-gene retinal disease. In terms of the first description of the disease, it follows an autosomal recessive inheritance pattern, which has been later linked to bi-allelic ABCA4 gene variants (STGD1). However, there are Stargardt-like diseases with mimicking phenotypes that are referred to as STGD3 and STGD4, and have a autosomal dominant inheritance due to defects with ELOVL4 or PROM1 genes, respectively. It is characterized by macular degeneration that begins in childhood, adolescence or adulthood, resulting in progressive loss of vision.

Ca<sub>v</sub>2.1 Protein-coding gene in the species Homo sapiens

Cav2.1, also called the P/Q voltage-dependent calcium channel, is a calcium channel found mainly in the brain. Specifically, it is found on the presynaptic terminals of neurons in the brain and cerebellum. Cav2.1 plays an important role in controlling the release of neurotransmitters between neurons. It is composed of multiple subunits, including alpha-1, beta, alpha-2/delta, and gamma subunits. The alpha-1 subunit is the pore-forming subunit, meaning that the calcium ions flow through it. Different kinds of calcium channels have different isoforms (versions) of the alpha-1 subunit. Cav2.1 has the alpha-1A subunit, which is encoded by the CACNA1A gene. Mutations in CACNA1A have been associated with various neurologic disorders, including familial hemiplegic migraine, episodic ataxia type 2, and spinocerebellar ataxia type 6.

<span class="mw-page-title-main">ABCA4</span> Mammalian protein found in Homo sapiens

ATP-binding cassette, sub-family A (ABC1), member 4, also known as ABCA4 or ABCR, is a protein which in humans is encoded by the ABCA4 gene.

<span class="mw-page-title-main">Peripherin 2</span> Protein-coding gene in the species Homo sapiens

Peripherin-2 is a protein, that in humans is encoded by the PRPH2 gene. Peripherin-2 is found in the rod and cone cells of the retina of the eye. Defects in this protein result in one form of retinitis pigmentosa, an incurable blindness.

<span class="mw-page-title-main">Bestrophin 1</span> Protein-coding gene in the species Homo sapiens

Bestrophin-1 (Best1) is a protein that, in humans, is encoded by the BEST1 gene.

<span class="mw-page-title-main">RPE65</span> Protein-coding gene in humans

Retinal pigment epithelium-specific 65 kDa protein, also known as retinoid isomerohydrolase, is an enzyme of the vertebrate visual cycle that is encoded in humans by the RPE65 gene. RPE65 is expressed in the retinal pigment epithelium and is responsible for the conversion of all-trans-retinyl esters to 11-cis-retinol during phototransduction. 11-cis-retinol is then used in visual pigment regeneration in photoreceptor cells. RPE65 belongs to the carotenoid oxygenase family of enzymes.

<i>CRX</i> (gene) Protein-coding gene in the species Homo sapiens

Cone-rod homeobox protein is a protein that in humans is encoded by the CRX gene.

<span class="mw-page-title-main">Twinkle (protein)</span> Human mitochondrial protein

Twinkle protein also known as twinkle mtDNA helicase is a mitochondrial protein that in humans is encoded by the TWNK gene located in the long arm of chromosome 10 (10q24.31).

<span class="mw-page-title-main">Hemicentin 1</span> Protein-coding gene in the species Homo sapiens

Hemicentin-1 is a protein that in humans is encoded by the HMCN1 gene.

<span class="mw-page-title-main">TTBK2</span> Protein-coding gene in the species Homo sapiens

Tau tubulin kinase 2 is a protein in humans that is encoded by the TTBK2 gene. This gene encodes a serine-threonine kinase that putatively phosphorylates tau and tubulin proteins. Mutations in this gene cause spinocerebellar ataxia type 11 (SCA11); a neurodegenerative disease characterized by progressive ataxia and atrophy of the cerebellum and brainstem.

<span class="mw-page-title-main">Meesmann corneal dystrophy</span> Medical condition

Meesmann corneal dystrophy (MECD) is a rare hereditary autosomal dominant disease that is characterized as a type of corneal dystrophy and a keratin disease. MECD is characterized by the formation of microcysts in the outermost layer of the cornea, known as the anterior corneal epithelium. The anterior corneal epithelium also becomes fragile. This usually affects both eyes rather than a single eye and worsens over time. There are two phenotypes, Meesmann corneal dystrophy 1 (MECD1) and Meesmann corneal dystrophy 2 (MECD2), which affect the genes KRT3 and KRT12, respectively. A heterozygous mutation in either of these genes will lead to a single phenotype. Many with Meesmann corneal dystrophy are asymptomatic or experience mild symptoms.

<span class="mw-page-title-main">Gillespie syndrome</span> Medical condition

Gillespie syndrome, also called aniridia, cerebellar ataxia and mental deficiency, is a rare genetic disorder. The disorder is characterized by partial aniridia, ataxia, and, in most cases, intellectual disability. It is heterogeneous, inherited in either an autosomal dominant or autosomal recessive manner. Gillespie syndrome was first described by American ophthalmologist Fredrick Gillespie in 1965.

<span class="mw-page-title-main">Autosomal dominant cerebellar ataxia</span> Medical condition

Autosomal dominant cerebellar ataxia (ADCA) is a form of spinocerebellar ataxia inherited in an autosomal dominant manner. ADCA is a genetically inherited condition that causes deterioration of the nervous system leading to disorder and a decrease or loss of function to regions of the body.

Occult macular dystrophy (OMD) is a rare inherited degradation of the retina, characterized by progressive loss of function in the most sensitive part of the central retina (macula), the location of the highest concentration of light-sensitive cells (photoreceptors) but presenting no visible abnormality. "Occult" refers to the degradation in the fundus being difficult to discern. The disorder is called "dystrophy" instead of "degradation" to distinguish its genetic origin from other causes, such as age. OMD was first reported by Y. Miyake et al. in 1989.

<span class="mw-page-title-main">Boucher-Neuhäuser syndrome</span> Medical condition

Boucher-Neuhäuser syndrome is a very rare genetic disorder which is characterized by a triad consisting of cerebellar ataxia, chorioretinal dystrophy, and hypogonadism.

<span class="mw-page-title-main">Autosomal recessive bestrophinopathy</span> Medical condition

Autosomal recessive bestrophinopathy is a rare genetic disorder characterized by central vision loss, retinopathy, absence of an electrooculogram light rise, and decreased electroretinogram. Other findings include dispersed punctate flecks, macular neurosensory retina fluid build-up, hyperopia, macular thinning, and angle-closure glaucoma.

<span class="mw-page-title-main">Progressive bifocal chorioretinal atrophy</span> Medical condition

Progressive bifocal chorioretinal atrophy, also known for its abbreviations PBCRA or CRAPB, is a rare, slowly progressive, autosomal dominant syndrome characterized by relatively large-sized atrophic hole-shaped lesions in the macular and nasal retina, myopia, low visual acuity, and nystagmus. It has been described in one family from Scotland and two families from France. The condition is caused by point mutations in a region in the long arm of chromosome 6 (6q16.2) that has been found responsible for the pathogenesis of other macular dystrophies.

References

  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000118402 - Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000032262 - Ensembl, May 2017
  3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. Zhang K, Kniazeva M, Han M, Li W, Yu Z, Yang Z, Li Y, Metzker ML, Allikmets R, Zack DJ, Kakuk LE, Lagali PS, Wong PW, MacDonald IM, Sieving PA, Figueroa DJ, Austin CP, Gould RJ, Ayyagari R, Petrukhin K (Jan 2001). "A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy". Nature Genetics. 27 (1): 89–93. doi:10.1038/83817. PMID   11138005. S2CID   23672516.
  6. "Entrez Gene: ELOVL4 elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 4".
  7. Agbaga M, Brush RS, Mandal MN, Henry K, Elliott MH, Anderson RE (2008-09-02). "Role of Stargardt-3 macular dystrophy protein (ELOVL4) in the biosynthesis of very long chain fatty acids". Proceedings of the National Academy of Sciences of the United States of America. 105 (35): 12843–12848. Bibcode:2008PNAS..10512843A. doi: 10.1073/pnas.0802607105 . ISSN   1091-6490. PMC   2525561 . PMID   18728184.
  8. Vasireddy V, Uchida Y, Salem N, Kim SY, Mandal MN, Reddy GB, Bodepudi R, Alderson NL, Brown JC, Hama H, Dlugosz A (2007-03-01). "Loss of functional ELOVL4 depletes very long-chain fatty acids (> or =C28) and the unique omega-O-acylceramides in skin leading to neonatal death". Human Molecular Genetics. 16 (5): 471–482. doi:10.1093/hmg/ddl480. ISSN   0964-6906. PMC   1839956 . PMID   17208947.
  9. Yeboah GK, Lobanova ES, Brush RS, Agbaga M (2021). "Very long chain fatty acid-containing lipids: a decade of novel insights from the study of ELOVL4". Journal of Lipid Research. 62: 100030. doi: 10.1016/j.jlr.2021.100030 . ISSN   0022-2275. PMC   8042400 . PMID   33556440.
  10. Bennett LD, Brush RS, Chan M, Lydic TA, Reese K, Reid GE, Busik JV, Elliott MH, Anderson RE (2014-04-10). "Effect of reduced retinal VLC-PUFA on rod and cone photoreceptors". Investigative Ophthalmology & Visual Science. 55 (5): 3150–3157. doi:10.1167/iovs.14-13995. ISSN   1552-5783. PMC   4027810 . PMID   24722693.
  11. Craig LB, Brush RS, Sullivan MT, Zavy MT, Agbaga M, Anderson RE (July 2019). "Decreased very long chain polyunsaturated fatty acids in sperm correlates with sperm quantity and quality". Journal of Assisted Reproduction and Genetics. 36 (7): 1379–1385. doi:10.1007/s10815-019-01464-3. ISSN   1573-7330. PMC   6642247 . PMID   31073727.
  12. Vasireddy V, Uchida Y, Salem N, Kim SY, Mandal MN, Reddy GB, Bodepudi R, Alderson NL, Brown JC, Hama H, Dlugosz A (2007-03-01). "Loss of functional ELOVL4 depletes very long-chain fatty acids (> or =C28) and the unique omega-O-acylceramides in skin leading to neonatal death". Human Molecular Genetics. 16 (5): 471–482. doi:10.1093/hmg/ddl480. ISSN   0964-6906. PMC   1839956 . PMID   17208947.
  13. Butovich IA (March 2009). "Cholesteryl esters as a depot for very long chain fatty acids in human meibum". Journal of Lipid Research. 50 (3): 501–513. doi: 10.1194/jlr.M800426-JLR200 . ISSN   0022-2275. PMC   2638107 . PMID   18836212.
  14. McMahon A, Lu H, Butovich IA (2014-05-01). "A role for ELOVL4 in the mouse meibomian gland and sebocyte cell biology". Investigative Ophthalmology & Visual Science. 55 (5): 2832–2840. doi:10.1167/iovs.13-13335. ISSN   1552-5783. PMC   4008046 . PMID   24677106.
  15. Hopiavuori BR, Deák F, Wilkerson JL, Brush RS, Rocha-Hopiavuori NA, Hopiavuori AR, Ozan KG, Sullivan MT, Wren JD, Georgescu C, Szweda L (February 2018). "Homozygous Expression of Mutant ELOVL4 Leads to Seizures and Death in a Novel Animal Model of Very Long-Chain Fatty Acid Deficiency". Molecular Neurobiology. 55 (2): 1795–1813. doi:10.1007/s12035-017-0824-8. ISSN   1559-1182. PMC   5820379 . PMID   29168048.
  16. Yeboah GK, Lobanova ES, Brush RS, Agbaga M (2021). "Very long chain fatty acid-containing lipids: a decade of novel insights from the study of ELOVL4". Journal of Lipid Research. 62: 100030. doi: 10.1016/j.jlr.2021.100030 . ISSN   1539-7262. PMC   8042400 . PMID   33556440.
  17. Zhang K, Kniazeva M, Han M, Li W, Yu Z, Yang Z, Li Y, Metzker ML, Allikmets R, Zack DJ, Kakuk LE (January 2001). "A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy". Nature Genetics. 27 (1): 89–93. doi:10.1038/83817. ISSN   1061-4036. PMID   11138005. S2CID   23672516.
  18. Bernstein PS, Tammur J, Singh N, Hutchinson A, Dixon M, Pappas CM, Zabriskie NA, Zhang K, Petrukhin K, Leppert M, Allikmets R (December 2001). "Diverse macular dystrophy phenotype caused by a novel complex mutation in the ELOVL4 gene". Investigative Ophthalmology & Visual Science. 42 (13): 3331–3336. ISSN   0146-0404. PMID   11726641.
  19. Maugeri A, Meire F, Hoyng CB, Vink C, Van Regemorter N, Karan G, Yang Z, Cremers FP, Zhang K (December 2004). "A novel mutation in the ELOVL4 gene causes autosomal dominant Stargardt-like macular dystrophy". Investigative Ophthalmology & Visual Science. 45 (12): 4263–4267. doi: 10.1167/iovs.04-0078 . ISSN   0146-0404. PMID   15557430.
  20. Cadieux-Dion M, Turcotte-Gauthier M, Noreau A, Martin C, Meloche C, Gravel M, Drouin CA, Rouleau GA, Nguyen DK, Cossette P (April 2014). "Expanding the clinical phenotype associated with ELOVL4 mutation: study of a large French-Canadian family with autosomal dominant spinocerebellar ataxia and erythrokeratodermia". JAMA Neurology. 71 (4): 470–475. doi:10.1001/jamaneurol.2013.6337. ISSN   2168-6157. PMID   24566826.
  21. Ozaki K, Doi H, Mitsui J, Sato N, Iikuni Y, Majima T, Yamane K, Irioka T, Ishiura H, Doi K, Morishita S (July 2015). "A Novel Mutation in ELOVL4 Leading to Spinocerebellar Ataxia (SCA) With the Hot Cross Bun Sign but Lacking Erythrokeratodermia: A Broadened Spectrum of SCA34". JAMA Neurology. 72 (7): 797–805. doi: 10.1001/jamaneurol.2015.0610 . ISSN   2168-6157. PMID   26010696. S2CID   6416150.
  22. Bourassa CV, Raskin S, Serafini S, Teive HA, Dion PA, Rouleau GA (August 2015). "A New ELOVL4 Mutation in a Case of Spinocerebellar Ataxia With Erythrokeratodermia". JAMA Neurology. 72 (8): 942–943. doi:10.1001/jamaneurol.2015.0888. ISSN   2168-6157. PMID   26258735.
  23. Bourque PR, Warman-Chardon J, Lelli DA, LaBerge L, Kirshen C, Bradshaw SH, Hartley T, Boycott KM (August 2018). "Novel ELOVL4 mutation associated with erythrokeratodermia and spinocerebellar ataxia (SCA 34)". Neurology. Genetics. 4 (4): e263. doi:10.1212/NXG.0000000000000263. ISSN   2376-7839. PMC   6066365 . PMID   30065956.
  24. Xiao C, Binkley EM, Rexach J, Knight-Johnson A, Khemani P, Fogel BL, Das S, Stone EM, Gomez CM (October 2019). "A family with spinocerebellar ataxia and retinitis pigmentosa attributed to an ELOVL4 mutation". Neurology. Genetics. 5 (5): e357. doi:10.1212/NXG.0000000000000357. ISSN   2376-7839. PMC   6812731 . PMID   31750392.
  25. Beaudin M, Sellami L, Martel C, Touzel-Deschênes L, Houle G, Martineau L, Lacroix K, Lavallée A, Chrestian N, Rouleau GA, Gros-Louis F (April 2020). "Characterization of the phenotype with cognitive impairment and protein mislocalization in SCA34". Neurology. Genetics. 6 (2): e403. doi:10.1212/NXG.0000000000000403. ISSN   2376-7839. PMC   7073455 . PMID   32211516.

Further reading